Windtree Cash vs Non Current Assets Total Analysis

WINT Stock  USD 0.50  0.01  1.96%   
Windtree Therapeutics financial indicator trend analysis is more than just analyzing Windtree Therapeutics current accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Windtree Therapeutics is a good investment. Please check the relationship between Windtree Therapeutics Cash and its Non Current Assets Total accounts. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Windtree Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For more information on how to buy Windtree Stock please use our How to Invest in Windtree Therapeutics guide.

Cash vs Non Current Assets Total

Cash vs Non Current Assets Total Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Windtree Therapeutics Cash account and Non Current Assets Total. At this time, the significance of the direction appears to have weak contrarian relationship.
The correlation between Windtree Therapeutics' Cash and Non Current Assets Total is -0.15. Overlapping area represents the amount of variation of Cash that can explain the historical movement of Non Current Assets Total in the same time period over historical financial statements of Windtree Therapeutics, assuming nothing else is changed. The correlation between historical values of Windtree Therapeutics' Cash and Non Current Assets Total is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cash of Windtree Therapeutics are associated (or correlated) with its Non Current Assets Total. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Non Current Assets Total has no effect on the direction of Cash i.e., Windtree Therapeutics' Cash and Non Current Assets Total go up and down completely randomly.

Correlation Coefficient

-0.15
Relationship DirectionNegative 
Relationship StrengthInsignificant

Cash

Cash refers to the most liquid asset of Windtree Therapeutics, which is listed under current asset account on Windtree Therapeutics balance sheet and usually includes currency, coins, checking accounts, and not deposited checks received from Windtree Therapeutics customers. The amounts must be unrestricted with restricted cash listed in a different Windtree Therapeutics account. The total amount of money in the form of currency that a company has in its possession. This includes all bills, coins, and funds in bank accounts.

Non Current Assets Total

The total value of a company's long-term assets, which are not expected to be converted into cash or used up within one year or the operating cycle, including property, plant, and equipment, and intangible assets.
Most indicators from Windtree Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Windtree Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Windtree Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For more information on how to buy Windtree Stock please use our How to Invest in Windtree Therapeutics guide.At this time, Windtree Therapeutics' Tax Provision is comparatively stable compared to the past year. Issuance Of Capital Stock is likely to gain to about 16.6 M in 2024, whereas Enterprise Value Multiple is likely to drop (0.80) in 2024.
 2021 2022 2023 2024 (projected)
Interest Expense114K53K50K47.5K
Depreciation And Amortization869K1.1M82K77.9K

Windtree Therapeutics fundamental ratios Correlations

0.240.060.240.96-0.46-0.360.210.210.710.470.730.45-0.260.280.380.850.45-0.320.210.03-0.32-0.2-0.390.69-0.17
0.240.670.540.040.03-0.240.620.150.490.230.650.350.42-0.330.30.060.35-0.35-0.1-0.13-0.350.5-0.5-0.08-0.14
0.060.670.87-0.05-0.230.060.64-0.380.07-0.080.380.480.55-0.250.45-0.190.49-0.44-0.35-0.41-0.440.48-0.32-0.460.39
0.240.540.870.15-0.140.010.79-0.350.10.00.460.330.46-0.270.240.10.34-0.44-0.41-0.42-0.440.31-0.31-0.180.46
0.960.04-0.050.15-0.59-0.150.070.130.530.270.520.5-0.440.270.430.780.5-0.150.19-0.03-0.15-0.31-0.160.61-0.15
-0.460.03-0.23-0.14-0.59-0.230.10.320.010.15-0.03-0.910.51-0.22-0.920.01-0.910.110.020.20.110.03-0.060.18-0.12
-0.36-0.240.060.01-0.15-0.23-0.13-0.51-0.7-0.99-0.640.14-0.11-0.560.13-0.450.120.76-0.13-0.610.760.060.9-0.63-0.08
0.210.620.640.790.070.1-0.13-0.160.280.120.550.130.44-0.390.060.180.14-0.34-0.15-0.38-0.340.49-0.36-0.050.21
0.210.15-0.38-0.350.130.32-0.51-0.160.280.550.15-0.28-0.220.34-0.260.33-0.28-0.17-0.060.78-0.17-0.29-0.290.59-0.18
0.710.490.070.10.530.01-0.70.280.280.720.930.120.160.210.090.730.13-0.460.450.1-0.460.08-0.710.67-0.31
0.470.23-0.080.00.270.15-0.990.120.550.720.67-0.070.030.59-0.070.52-0.05-0.760.140.63-0.76-0.11-0.880.70.06
0.730.650.380.460.52-0.03-0.640.550.150.930.670.220.310.10.160.690.23-0.590.24-0.03-0.590.18-0.770.54-0.11
0.450.350.480.330.5-0.910.140.13-0.280.12-0.070.22-0.30.050.99-0.081.0-0.22-0.05-0.21-0.220.21-0.12-0.250.04
-0.260.420.550.46-0.440.51-0.110.44-0.220.160.030.31-0.3-0.36-0.32-0.09-0.3-0.14-0.06-0.32-0.140.26-0.23-0.190.04
0.28-0.33-0.25-0.270.27-0.22-0.56-0.390.340.210.590.10.05-0.360.110.240.07-0.530.170.65-0.53-0.28-0.440.380.29
0.380.30.450.240.43-0.920.130.06-0.260.09-0.070.160.99-0.320.11-0.150.99-0.23-0.03-0.16-0.240.22-0.12-0.30.07
0.850.06-0.190.10.780.01-0.450.180.330.730.520.69-0.08-0.090.24-0.15-0.07-0.210.290.08-0.21-0.34-0.350.89-0.2
0.450.350.490.340.5-0.910.120.14-0.280.13-0.050.231.0-0.30.070.99-0.07-0.25-0.07-0.19-0.250.2-0.14-0.250.06
-0.32-0.35-0.44-0.44-0.150.110.76-0.34-0.17-0.46-0.76-0.59-0.22-0.14-0.53-0.23-0.21-0.250.16-0.361.0-0.150.91-0.23-0.57
0.21-0.1-0.35-0.410.190.02-0.13-0.15-0.060.450.140.24-0.05-0.060.17-0.030.29-0.070.16-0.010.160.33-0.020.28-0.35
0.03-0.13-0.41-0.42-0.030.2-0.61-0.380.780.10.63-0.03-0.21-0.320.65-0.160.08-0.19-0.36-0.01-0.36-0.29-0.370.450.05
-0.32-0.35-0.44-0.44-0.150.110.76-0.34-0.17-0.46-0.76-0.59-0.22-0.14-0.53-0.24-0.21-0.251.00.16-0.36-0.150.91-0.23-0.57
-0.20.50.480.31-0.310.030.060.49-0.290.08-0.110.180.210.26-0.280.22-0.340.2-0.150.33-0.29-0.15-0.16-0.450.19
-0.39-0.5-0.32-0.31-0.16-0.060.9-0.36-0.29-0.71-0.88-0.77-0.12-0.23-0.44-0.12-0.35-0.140.91-0.02-0.370.91-0.16-0.39-0.23
0.69-0.08-0.46-0.180.610.18-0.63-0.050.590.670.70.54-0.25-0.190.38-0.30.89-0.25-0.230.280.45-0.23-0.45-0.39-0.26
-0.17-0.140.390.46-0.15-0.12-0.080.21-0.18-0.310.06-0.110.040.040.290.07-0.20.06-0.57-0.350.05-0.570.19-0.23-0.26
Click cells to compare fundamentals

Windtree Therapeutics Account Relationship Matchups

Windtree Therapeutics fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets119.0M112.9M74.8M38.0M32.4M42.3M
Short Long Term Debt Total20.5M3.8M2.9M2.3M16.8M9.8M
Other Current Liab5.2M3.0M2.9M1.1M2.5M2.6M
Total Current Liabilities7.8M6.1M4.9M2.5M4.0M3.8M
Total Stockholder Equity74.9M69.6M41.9M10.0M3.4M3.2M
Net Debt(16.3M)(13.1M)(19.5M)(3.9M)12.5M13.1M
Retained Earnings(685.1M)(717.7M)(785.3M)(824.5M)(844.8M)(802.6M)
Accounts Payable1.7M1.2M693K249K809K768.6K
Common Stock Shares Outstanding218.6K20K30K40K220K231K
Liabilities And Stockholders Equity119.0M112.9M74.8M38.0M32.4M42.3M
Non Current Liabilities Total36.2M37.2M28.0M25.5M25.0M14.1M
Other Stockholder Equity760.0M787.2M827.2M834.5M848.2M890.6M
Total Liab44.0M43.3M32.9M27.9M29.0M21.5M
Total Current Assets23.9M18.1M23.5M7.4M5.4M5.1M
Short Term Debt911K2.0M1.4M1.1M669K635.6K
Property Plant And Equipment Net2.2M1.8M3.4M2.1M1.6M2.5M
Cash22.6M16.9M22.3M6.2M4.3M4.1M
Non Current Assets Total95.1M94.8M51.3M30.6M27.0M18.0M
Cash And Short Term Investments22.6M16.9M22.3M6.2M4.3M4.1M
Common Stock Total Equity3K32K41K17K15.3K14.5K
Other Current Assets1.3M2.4M2.3M1.2M1.1M956.1K
Property Plant And Equipment Gross2.2M1.8M3.4M2.1M5.4M5.6M
Common Stock41K17K28K6K5.4K5.1K
Other Liab15.7M15.8M19.6M10.9M12.6M13.2M
Property Plant Equipment802K798K1.8M3.4M3.1M2.1M
Net Tangible Assets52.4M(17.8M)(23.2M)(5.9M)(5.3M)(5.0M)
Retained Earnings Total Equity(637.1M)(657.6M)(685.1M)(717.7M)(645.9M)(678.2M)
Capital Surpluse616.2M728.8M763.1M790.3M908.8M662.9M
Short Long Term Debt161K352K294K252K233K221.4K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Windtree Stock Analysis

When running Windtree Therapeutics' price analysis, check to measure Windtree Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Windtree Therapeutics is operating at the current time. Most of Windtree Therapeutics' value examination focuses on studying past and present price action to predict the probability of Windtree Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Windtree Therapeutics' price. Additionally, you may evaluate how the addition of Windtree Therapeutics to your portfolios can decrease your overall portfolio volatility.